Mainstream

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Icon signals $8B full-year revenue midpoint as metabolic and obesity trial momentum builds

Post ContenticlrRead More

You might also be interested in reading Goldman Sachs and BNY join forces to transform $7.1 trillion money market industry with digital tokens.

July 24, 2025
In Mainstream